Developer docs
API playgroundTry for free, no card

Search company profiles

DCH Auriga

Full company profile

uuid000fitw

Namestring
DCH Auriga
Legal namestring
DCH Auriga (Hong Kong) Ltd
Websiteurl
dchauriga.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

DCH Auriga is an Asia-based integrated market management provider specializing exclusively in the healthcare sector. The company offers three core solution categories: Market Management Solutions (regulatory and import support, marketing, sales, account management, merchandising, and home health delivery), Supply Chain Solutions (warehousing, cold chain, transport, pick and pack, value-added services, and reverse logistics), and Products & Networks (distribution of pharmaceuticals, medical devices, diagnostics, OTC, nutrition, surgical equipment, consumables, and consumer health products). Operations span 10 Asian economies — Hong Kong, Macau, mainland China, Singapore, Malaysia, Brunei, Indonesia, Thailand, the Philippines, and Vietnam — served through wholly-owned local subsidiaries and dedicated distribution centers, including Wyler Centre 1, Hong Kong's only building dedicated entirely to healthcare warehousing and distribution.

The company's technology stack centers on a digital supply chain platform featuring JDA Warehouse Management System integrated with ERP (deployed in Singapore and Hong Kong), RFID tracking, real-time temperature monitoring with digital temp-tags, and qualified cold chain capabilities across multiple temperature bands (2-8°C, less than -18°C, less than -25°C, 0-4°C). It maintains sector-specific quality certifications including ISO 13485:2016, ISO 9001, GDP, and GDPMD across multiple jurisdictions.

DCH Auriga generates revenue primarily through transaction-fee distribution and logistics services for pharmaceutical and medical device principals, supplemented by professional-services revenue from commercial market management engagements. Its named customer base includes Pfizer, Johnson & Johnson, Sanofi, Gilead, MSD, GE Healthcare, Baxter, and Fosun Pharma, with over 500 brands distributed across more than 10,000 points of sale. The company is a wholly-owned subsidiary of Dah Chong Hong Holdings (CITIC Pacific/CITIC Limited group).

Short descriptiontext

DCH Auriga is an Asia-based integrated market management provider specializing exclusively in healthcare, offering end-to-end regulatory, commercial, supply chain, and distribution services across 10 Asian economies for pharmaceutical and medical device principals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersKwai Tsing, Hong Kong SAR China
HQ citystring
Kwai Tsing
HQ countrystring
Hong Kong SAR China
HQ regionstring
Asia
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare distribution, pharmaceutical logistics, cold chain management, market access services, medical device distribution
Industry4 codes
1Pharmaceutical & Healthcare Distribution Centers (GDP-compliant)
CodeTLALAEAEPrimaryYes
2Temperature-Controlled Distribution Centers (DCs)
CodeAFAOAFAEPrimaryNo
3Retail & Wholesale Distribution Centers (Dry DCs)
CodeTLALAAADPrimaryNo
4Reverse Logistics & Returns Distribution Centers
CodeTLALAEAMPrimaryNo
NAICS code4 codes
  • Refrigerated Warehousing and Storage493120
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • General Warehousing and Storage493110
  • Warehousing and Storage493
SIC code3 codes
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Public Warehousing & Storage4220
  • Wholesale-Professional & Commercial Equipment & Supplies5040
Product category
Healthcare Distribution Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Distribution and Logistics Services
TypeTransaction Fee
Description

Core revenue from managing end-to-end supply chains for healthcare products across Asia, including warehousing, transport, and delivery services.

dchauriga.com
2Market Management Solutions
TypeProfessional Services
Description

Commercial services including regulatory compliance, marketing, sales, account management, and consultation services for healthcare principals.

dchauriga.com
3Product Distribution
TypeTransaction Fee
Description

Distribution of pharmaceutical, medical device, diagnostics, OTC, nutrition, surgical equipment, consumables, and health and beauty products across their network.

dchauriga.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

DCH Auriga provides end-to-end integrated market management and supply chain solutions for the healthcare industry across 10 Asian economies. The company combines commercial services—including regulatory compliance, marketing, sales, and account management—with logistics services such as warehousing, cold chain storage, transport, and home delivery for pharmaceutical, medical device, diagnostics, OTC, nutrition, surgical equipment, consumables, and consumer health products from world-leading principals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Distribution across 10 Asian economies serving more than 500 brands at over 10,000 points of sale
+1 more record
Product overview1 text field

DCH Auriga is an Asia-based integrated market management provider specializing in healthcare. The company offers three core solution categories: Market Management Solutions (covering regulatory compliance, marketing, sales, and home health services), Supply Chain Solutions (including warehousing, cold chain, transport, and reverse logistics), and Products & Networks (spanning pharmaceuticals, medical devices, diagnostics, and consumer health products). The company operates as a unified platform serving healthcare companies across 10 Asian economies, combining commercial and logistics services to enable partners to access market opportunities in Asia.

Product and service3 records
1Market Management Solutions
CategoryMarket Management Services
Description

Comprehensive commercial services including consultation and market intelligence, regulatory and import support, ethical advocacy, consumer marketing, digital and omni-channel services, sales and account services, merchandising, and home health delivery for healthcare principals expanding across Asia.

2Supply Chain Solutions
CategoryLogistics and Warehousing Services
Description

End-to-end supply chain management including customs management, warehouse management, pick and pack operations, value added services (relabeling, repacking, kitting), cold chain solutions, transport and delivery, reverse logistics, and distributor transition management for healthcare products.

3Products & Networks
CategoryProduct Distribution Services
Description

Product marketing and distribution expertise spanning pharmaceuticals, medical devices, diagnostics, OTC, nutrition, surgical equipment, consumables, and health and beauty products, with access to professional healthcare networks including government hospitals, private hospitals, clinics, pharmacies, and retailers across Asia.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2022-03-02
Description

Strategic cooperation between DCH Auriga and HKIOC to support Zhongshan Chenxinghai Hospital in offering Hong Kong-approved medical treatments to Greater Bay Area patients, supporting a National State Council initiative.

2Zhongshan Chenxinghai Hospital
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2022-03-02
Description

Partnership under the GBA healthcare initiative where DCH Auriga and HKIOC support the hospital to offer Hong Kong-approved medical treatments to Greater Bay Area patients.

dchauriga.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-02-27
Description

DCH Auriga was selected as the exclusive logistics partner for the distribution of Fosun Pharma-BioNTech COVID-19 vaccine (COMIRNATY) in Hong Kong. They managed the storage and delivery of the vaccine.

Strategic tierStrategicTypeChannel Partner/ Reseller/ Distributor
Description

DCH Auriga supports Baxter with home delivery for chronic care including renal dialysis solutions, appointed as sole distributor for renal dialysis solution in Hong Kong in 2015.

Recent move14 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat6 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries9 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DCH Auriga

Healthcare Distribution Servicesdchauriga.com

DCH Auriga is an Asia-based integrated market management provider specializing exclusively in healthcare, offering end-to-end regulatory, commercial, supply chain, and distribution services across 10 Asian economies for pharmaceutical and medical device principals.

What DCH Auriga does

DCH Auriga is an Asia-based integrated market management provider specializing exclusively in the healthcare sector. The company offers three core solution categories: Market Management Solutions (regulatory and import support, marketing, sales, account management, merchandising, and home health delivery), Supply Chain Solutions (warehousing, cold chain, transport, pick and pack, value-added services, and reverse logistics), and Products & Networks (distribution of pharmaceuticals, medical devices, diagnostics, OTC, nutrition, surgical equipment, consumables, and consumer health products). Operations span 10 Asian economies — Hong Kong, Macau, mainland China, Singapore, Malaysia, Brunei, Indonesia, Thailand, the Philippines, and Vietnam — served through wholly-owned local subsidiaries and dedicated distribution centers, including Wyler Centre 1, Hong Kong's only building dedicated entirely to healthcare warehousing and distribution.

The company's technology stack centers on a digital supply chain platform featuring JDA Warehouse Management System integrated with ERP (deployed in Singapore and Hong Kong), RFID tracking, real-time temperature monitoring with digital temp-tags, and qualified cold chain capabilities across multiple temperature bands (2-8°C, less than -18°C, less than -25°C, 0-4°C). It maintains sector-specific quality certifications including ISO 13485:2016, ISO 9001, GDP, and GDPMD across multiple jurisdictions.

DCH Auriga generates revenue primarily through transaction-fee distribution and logistics services for pharmaceutical and medical device principals, supplemented by professional-services revenue from commercial market management engagements. Its named customer base includes Pfizer, Johnson & Johnson, Sanofi, Gilead, MSD, GE Healthcare, Baxter, and Fosun Pharma, with over 500 brands distributed across more than 10,000 points of sale. The company is a wholly-owned subsidiary of Dah Chong Hong Holdings (CITIC Pacific/CITIC Limited group).

DCH Auriga firmographics

Firmographics
Name
DCH Auriga
Legal name
DCH Auriga (Hong Kong) Ltd
Website
https://dchauriga.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
251–500 employees
Short description
DCH Auriga is an Asia-based integrated market management provider specializing exclusively in healthcare, offering end-to-end regulatory, commercial, supply chain, and distribution services across 10 Asian economies for pharmaceutical and medical device principals.
Ownership category
akta.pro rank

DCH Auriga industry classification

Industry
Product category
Healthcare Distribution Services
NAICS
Refrigerated Warehousing and Storage (493120), Drugs and Druggists' Sundries Merchant Wholesalers (42421), General Warehousing and Storage (493110), Warehousing and Storage (493)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Public Warehousing & Storage (4220), Wholesale-Professional & Commercial Equipment & Supplies (5040)
akta.pro primary industry
Pharmaceutical & Healthcare Distribution Centers (GDP-compliant) (TLALAEAE)
akta.pro secondary industries
Temperature-Controlled Distribution Centers (DCs) (AFAOAFAE), Retail & Wholesale Distribution Centers (Dry DCs) (TLALAAAD), Reverse Logistics & Returns Distribution Centers (TLALAEAM)

Keywords

  • Healthcare distribution
  • Pharmaceutical logistics
  • Cold chain management
  • Market access services
  • Medical device distribution

Where DCH Auriga is headquartered

Location

Headquarters

HQ city
Kwai Tsing
HQ country
Hong Kong SAR China
HQ region
Asia

Offices10 records

Markets served

DCH Auriga business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Distribution and Logistics Services: Core revenue from managing end-to-end supply chains for healthcare products across Asia, including warehousing, transport, and delivery services.
  2. Market Management Solutions: Commercial services including regulatory compliance, marketing, sales, account management, and consultation services for healthcare principals.
  3. Product Distribution: Distribution of pharmaceutical, medical device, diagnostics, OTC, nutrition, surgical equipment, consumables, and health and beauty products across their network.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

DCH Auriga product offering

Product offering

Core offering

DCH Auriga provides end-to-end integrated market management and supply chain solutions for the healthcare industry across 10 Asian economies. The company combines commercial services—including regulatory compliance, marketing, sales, and account management—with logistics services such as warehousing, cold chain storage, transport, and home delivery for pharmaceutical, medical device, diagnostics, OTC, nutrition, surgical equipment, consumables, and consumer health products from world-leading principals.

Product overview

DCH Auriga is an Asia-based integrated market management provider specializing in healthcare. The company offers three core solution categories: Market Management Solutions (covering regulatory compliance, marketing, sales, and home health services), Supply Chain Solutions (including warehousing, cold chain, transport, and reverse logistics), and Products & Networks (spanning pharmaceuticals, medical devices, diagnostics, and consumer health products). The company operates as a unified platform serving healthcare companies across 10 Asian economies, combining commercial and logistics services to enable partners to access market opportunities in Asia.

Differentiator

Problem solved

Functional benefit

Products and services

  • Market Management Solutions Comprehensive commercial services including consultation and market intelligence, regulatory and import support, ethical advocacy, consumer marketing, digital and omni-channel services, sales and account services, merchandising, and home health delivery for healthcare principals expanding across Asia.
  • Supply Chain Solutions End-to-end supply chain management including customs management, warehouse management, pick and pack operations, value added services (relabeling, repacking, kitting), cold chain solutions, transport and delivery, reverse logistics, and distributor transition management for healthcare products.
  • Products & Networks Product marketing and distribution expertise spanning pharmaceuticals, medical devices, diagnostics, OTC, nutrition, surgical equipment, consumables, and health and beauty products, with access to professional healthcare networks including government hospitals, private hospitals, clinics, pharmacies, and retailers across Asia.

Quantifiable outcome

  • Distribution across 10 Asian economies serving more than 500 brands at over 10,000 points of sale
  • +1 more outcomes

Companies that use DCH Auriga

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles3 records

DCH Auriga technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

DCH Auriga partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered strategic and core.

  • Hong Kong Integrated Oncology Centre (HKIOC)strategicStrategic or Co-development Partner · 2 March 2022Strategic cooperation between DCH Auriga and HKIOC to support Zhongshan Chenxinghai Hospital in offering Hong Kong-approved medical treatments to Greater Bay Area patients, supporting a National State Council initiative.
  • Zhongshan Chenxinghai HospitalstrategicStrategic or Co-development Partner · 2 March 2022Partnership under the GBA healthcare initiative where DCH Auriga and HKIOC support the hospital to offer Hong Kong-approved medical treatments to Greater Bay Area patients.
  • Fosun PharmacoreChannel Partner/ Reseller/ Distributor · 27 February 2021DCH Auriga was selected as the exclusive logistics partner for the distribution of Fosun Pharma-BioNTech COVID-19 vaccine (COMIRNATY) in Hong Kong. They managed the storage and delivery of the vaccine.
  • BaxterstrategicChannel Partner/ Reseller/ DistributorDCH Auriga supports Baxter with home delivery for chronic care including renal dialysis solutions, appointed as sole distributor for renal dialysis solution in Hong Kong in 2015.

Scale indicators5 records

Recent moves14 records

Expansion highlights5 records

DCH Auriga competitors and assessment

Company assessment

Market position

Competitive moat6 records

Key highlights7 records

Customer concentration

DCH Auriga social profiles

Digital presence

DCH Auriga compliance and trust

Trust signal

Compliance10 records

DCH Auriga financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DCH Auriga leadership team

Management profile

Number of profiles

DCH Auriga subsidiaries and ownership

Company hierarchy

Subsidiaries9 records

DCH Auriga funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DCH Auriga M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DCH Auriga

What does DCH Auriga do?

DCH Auriga provides end-to-end integrated market management and supply chain solutions for the healthcare industry across 10 Asian economies. The company combines commercial services—including regulatory compliance, marketing, sales, and account management—with logistics services such as warehousing, cold chain storage, transport, and home delivery for pharmaceutical, medical device, diagnostics, OTC, nutrition, surgical equipment, consumables, and consumer health products from world-leading principals.

Is DCH Auriga a public or private company?

DCH Auriga is a private company. It is classified as corporate owned and is currently operating.

When was DCH Auriga founded?

DCH Auriga was founded in 2017. It employs 251 to 500 people.

Where is DCH Auriga based?

DCH Auriga is headquartered in Kwai Tsing, Hong Kong SAR China, in the Asia region.

How does DCH Auriga make money?

Three revenue lines are on record. Distribution and Logistics Services are the primary driver. The others are market Management Solutions and product Distribution.

Does DCH Auriga have an API?

No public API is recorded for DCH Auriga.

What industry is DCH Auriga in?

DCH Auriga's product category is Healthcare Distribution Services. Its primary akta.pro industry code is TLALAEAE, Pharmaceutical & Healthcare Distribution Centers (GDP-compliant), with a secondary code of AFAOAFAE, Temperature-Controlled Distribution Centers (DCs). Its NAICS code is 493120 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales